Tech Center 3700 • Art Units: 3762 3792
This examiner grants 83% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19354755 | CATHETER APPARATUSES AND SYSTEMS FOR PULSED ELECTRIC FIELD ABLATION THERAPY | Non-Final OA | Alpfa Medical, Inc. |
| 18604694 | COMBINED RF FRACTIONAL AND NON-FRACTIONAL TREATMENT | Non-Final OA | Inmode Ltd. |
| 18683400 | DETECTING OPERATIONAL CONDITIONS OF MECHANICAL CIRCULATORY SUPPORT DEVICES | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 19207303 | TREATMENT PARADIGMS FOR NERVE STIMULATION | Non-Final OA | ElectroCore, Inc. |
| 18277179 | METHOD AND SYSTEM FOR PROCESSING INPUT SIGNALS USING MACHINE LEARNING FOR NEURAL ACTIVATION | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18616827 | PERCUTANEOUS CIRCULATORY SUPPORT DEVICE INCLUDING PROXIMAL GUIDEWIRE LUMEN | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18756903 | INTRACARDIAC UNIPOLAR FAR FIELD CANCELATION USING MULTIPLE ELECTRODE CATHETERS AND METHODS FOR CREATING AN ECG DEPTH AND RADIAL LENS | Non-Final OA | Biosense Webster (Israel) Ltd. |
| 18424921 | GUI TO DISPLAY LOCATIONS OF EARLY AND LATE LOCAL ACTIVATION TIMES (LAT) IN LAT MAP AND CORRECT THE MAP | Non-Final OA | BIOSENSE WEBSTER (ISRAEL) LTD. |
| 18707353 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE MONITORING DEVICE | Non-Final OA | Medtronic, Inc. |
| 18184813 | DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT | Final Rejection | BTL Healthcare Technologies A.S. |
| 17518243 | DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT | Non-Final OA | BTL Healthcare Technologies a.s. |
| 18435131 | ACTIVELY INFLUENCING A STATE OF A USER OF A COMPUTING DEVICE | Non-Final OA | Nvidia Corporation |
| 18460890 | MODULE AND WEARABLE DEVICE | Final Rejection | CASIO COMPUTER CO., LTD. |
| 18692015 | CLINICIAN TASK PRIORITIZATION | Non-Final OA | Cochlear Limited |
| 18029500 | ADVANCED SURGICALLY IMPLANTABLE TECHNOLOGIES | Non-Final OA | COCHLEAR LIMITED |
| 18509207 | WEARABLE INSOLE FOR ENHANCED DIABETIC FOOT ULCER WOUND HEALING | Non-Final OA | Board of Trustees of Western Michigan University |
| 18752446 | AORTIC STENOSIS SEVERITY QUANTIFICATION USING HEART SOUNDS | Non-Final OA | Cardiac Pacemakers, Inc. |
| 18441857 | SENSOR DATA DISPLAY BOUNDARY DETERMINATION | Non-Final OA | Cardiac Pacemakers, Inc. |
| 18540388 | HEADER BORE LABELING | Final Rejection | Cardiac Pacemakers, Inc. |
| 18587564 | EAR-WORN DEVICES INCLUDING DIAGNOSTICS AND MONITORING FEATURES FOR DENTAL HEALTH | Non-Final OA | Starkey Laboratories, Inc. |
| 18716547 | DEVICE FOR STIMULATING VITAMIN D PRODUCTION | Non-Final OA | Dyson Technology Limited |
| 18692402 | MEDICAL HANDLING SYSTEM | Final Rejection | Medizinische Hochschule Hannover |
| 18727687 | APPLICATOR AND APPLICATOR ASSEMBLY FOR MEDICAL DEVICE | Non-Final OA | l-SENS, INC. |
| 18658543 | Integrated Header-Based Data and Charging Antenna for an Implantable Medical Device | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18645034 | SYSTEMS AND METHODS FOR MODIFYING STIMULATION IN RESPONSE TO A CHANGE IN A SYMPTOM, THERAPEUTIC EFFECT, OR SIDE EFFECT | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18757028 | TRANSDUCERS FOR DELIVERY OF TUMOR TREATING FIELDS AND CAPABLE OF REDUCING CREASING | Non-Final OA | Novocure GmbH |
| 18374080 | Reducing Electrosensation While Treating a Subject Using Alternating Electric Fields by Deactivating Selected Electrode Elements | Final Rejection | Novocure GmbH |
| 18716796 | MONITORING SYSTEM, WEARABLE TERMINAL, MONITORING METHOD, AND PROGRAM | Non-Final OA | TEIKYO UNIVERSITY |
| 18694702 | METHOD FOR CONTROLLING AN ARTICULATED END EFFECTOR ACTUATED BY ONE OR MORE ACTUATION TENDONS OF A SURGICAL INSTRUMENT OF A ROBOTIC SYSTEM FOR SURGERY, AND RELATED ROBOTIC SYSTEM FOR SURGERY | Non-Final OA | MEDICAL MICROINSTRUMENTS, INC. |
| 18645220 | METHODS, APPARATUSES, AND SYSTEMS FOR THE TREATMENT OF DISEASE STATES AND DISORDERS | Non-Final OA | Galvanize Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy